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Abstract
Sox7 and Sox18 are members of the F-subgroup of Sox transcription factors family and are mostly expressed in endothelial compartments. In
humans, dominant mutations in Sox18 are the underlying cause of the severe hypotrichosis–lymphedema–telangiectasia disorder characterized by
vascular defects. However little is known about which vasculogenic processes Sox7 and Sox18 regulate in vivo. We cloned the orthologs of Sox7
and Sox18 in zebrafish, analysed their expression pattern and performed functional analyses. Both genes are expressed in the lateral plate
mesoderm during somitogenesis. At later stages, Sox18 is expressed in all axial vessels whereas Sox7 expression is mainly restricted to the dorsal
aorta. Knockdown of Sox7 or Sox18 alone failed to reveal any phenotype. In contrast, blocking the two genes simultaneously led to embryos
displaying dysmorphogenesis of the proximal aorta and arteriovenous shunts, all of which can account for the lack of circulation observed in the
trunk and tail. Gene expression analyses performed with general endothelial markers on double morphants revealed that Sox7 and Sox18 are
dispensable for the initial specification and positioning of the major trunk vessels. However, morphants display ectopic expression of the venous
Flt4 marker in the dorsal aorta and a concomitant reduction of the artery-specific markers EphrinB2a and Gridlock. The striking similarities
between the phenotype of Sox7/Sox18 morphants and Gridlock mutants strongly suggest that Sox7 and Sox18 control arterial–venous identity by
regulating Gridlock expression.
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Vasculogenesis is the process of de novo blood vessel
formation that involves migration and differentiation of
precursors of endothelial cells, in response to local cues (such
as growth factors and extracellular matrix) (Risau, 1997). In
angiogenesis, new blood vessels sprout from pre-existing ones
and further remodelled to form mature blood vessels (Flamme et
al., 1997). In zebrafish, as in other species, blood vessel
development is an exquisite process that requires genetic
interactions between several signaling molecules, ligands,
tyrosine kinase-type receptors and their downstream effectors⁎ Corresponding author. Fax: +32 4 366 4198.
E-mail address: h.pendeville@ulg.ac.be (H. Pendeville).
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doi:10.1016/j.ydbio.2008.01.028(Weinstein, 2002a). A wealth of information concerning key
players of the VEGF pathway or molecules involved in vessel
guidance is now available (Bielenberg and Klagsbrun, 2007;
Goishi and Klagsbrun, 2004; Torres-Vazquez et al., 2004).
However, aside from members of the Ets family (Patterson and
Patient, 2006; Pham et al., 2007), very few transcription factors
have been shown to participate in blood vessel development.
Members of the SRY-related high mobility group box (Sox)
superfamily encode transcription factors involved in develop-
mental processes. Sox proteins bind the heptameric consensus
sequence 5′-(A/T)(A/T)CCA(A/T)G-3′via their HMG domain.
To date, the vertebrate Sox family comprises about 26 genes that
can be classified into 7 subgroups (A–G) based on sequence
similarity (Bowles et al., 2000). Sox7, Sox18 and Sox 17 belong
to the F-subgroup and have been implicated in endothelial
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Sakamoto et al., 2007).
Several recessive and dominant mutations in the Sox18 gene
are the underlying cause of the severe human hypotrichosis–
lymphedema–telangiectasia disorder which is characterized by
chronic edema at the extremities and abnormal dilation of
capillary and arterioles (Irrthum et al., 2003). In the mutant
ragged (Ra) mice, which display defective cardiovascular and
hair follicle formation, mutations in the transactivation domain
of Sox18 lead the protein to act in a dominant-negative manner
(Pennisi et al., 2000b). As mice null for Sox18 have only a mild
coat defect but no developmental vascular-associated pheno-
type (Pennisi et al., 2000a), it was suggested that there is a
functional redundancy amongst some Sox proteins from the
same subgroup, that can account for the mild phenotype
observed in these mice. In pathological situations however, the
Sox18 null mice present reduced tumor vascularization and
subsequent growth, suggesting that interfering with Sox18
function impairs tumoral angiogenesis and growth (Young et
al., 2006). The role of Sox18 in angiogenesis is further
supported by the observation that Sox18 is detected in
granulation tissue during wound healing in adult mice (Darby
et al., 2001). During mouse embryogenesis, Sox18 expression is
observed in endothelial cells of blood vessels, in the heart and in
the mesenchyme underlying the vibrissae and pelage hair
follicle (Pennisi et al., 2000b). In human, as in mouse, Sox18
expression is not restricted to embryonic development and can
be detected in coronary atherosclerotic lesions (Garcia-Ramirez
et al., 2005). Studies have also shown that Sox18 is essential for
the expression of VCAM-1 (vascular cell adhesion molecule-1)
and interacts with the muscle and endothelial transcription
factor MEF2C (Hosking et al., 2001; Hosking et al., 2004).
The physiological function of Sox7 has been less documen-
ted. During mouse development, Sox7 expression is mainly
detected within cells of the developing vasculature such as the
small branching vessels and intersomitic vessels, but also in the
heart, lung and gut (Takash et al., 2001).
The mechanism underlying Sox7 and Sox18 function in the
vasculature remains to be elucidated. In zebrafish, although
blood circulation is established early, passive oxygen diffusion
allows embryos showing important vasculogenic defects to
survive for a long period of time (up to 4 days post-fertilization),
thereby facilitating the characterization of the phenotype
(Weinstein, 2002b). In this report, we therefore used the
zebrafish as a valuable model for analysing the role of Sox7 and
Sox18 in vascular development.
Results
Cloning of the zebrafish Sox7 and Sox18 genes
In the process of decrypting the role of Sox7 and Sox18
genes in zebrafish vasculogenesis, we searched the zebrafish
orthologs by mining EST and genomic databases. This in silico
search allowed us to identify the Sox7 and Sox18 genes, both
present as a single copy in the zebrafish genome. We amplified
the Sox7 and Sox18 cDNAS by RT-PCR on mRNAs rangingfrom 2 hpf to 31 hpf. The predicted amino acid sequences
indicate that zebrafish Sox18 (XP_694383) and Sox7
(AY423014) present respectively 61% and 73% identity over
their entire sequence with their human orthologs with a nearly
perfect conservation in the HMG box (Fig. 1A). Dr-Sox18 and
Dr-Sox7 are the true orthologs of the human genes as the
phylogenetic tree clearly shows that the zebrafish Sox18 and
Sox7 proteins fit into the Sox18 and Sox7 clade, respectively
(Fig. 1B). Moreover synteny occurs between the zebrafish and
the human chromosomal regions harboring the Sox18 and Sox7
genes. Indeed, the zebrafish Sox18 gene, located on chromo-
some 23, is directly adjacent to the tcea2 gene like its human
counterpart which is located on chromosome 20. Similarly, Dr-
Sox7 and Hs-Sox7 locus on chromosome 20 and 8, respectively
share the same gene organization (Sox7, PinX1, Q96KT1 and
MTMR9) (data not shown).
Sox7 and Sox18 have overlapping and distinct expression
patterns in the endothelial compartment
We next assessed Sox7 and Sox18 expression during
zebrafish embryogenesis. Whole mount in situ hybridizations
performed on zebrafish embryos at different stages of develop-
ment showed no expression of Sox7 and Sox18 before the end of
gastrulation (data not shown). Sox7 and Sox18 transcripts are
first detected at bud stage and are located in bilateral stripes in
the posterior lateral plate mesoderm (Figs. 2A, F). During
somitogenesis, these expression domains extend along the
posterior part of the lateral mesoderm whereas a signal
corresponding to the anterior lateral plate mesoderm also starts
to appear in Sox7 and Sox18-stained embryos (Figs. 2B, G).
During these early stages, Sox18 transcripts are expressed at
lower levels than Sox7. At 18 somites stage, Sox7 and Sox18
transcripts are found in the head and in the presumptive axial
vessels that start to coalesce and differentiate at the midline to
generate the dorsal aorta and the axial vein (Figs. 2C, H). At
24 hpf, by the time circulation starts in zebrafish, Sox7 and
Sox18 are expressed in the vasculature within the head, trunk
and tail (Figs. 2D, I). Closer inspection of the staining reveals
that Sox18 expression is detected in the dorsal aorta, the
intersomitic vessels and in the axial vein (Fig. 2J). Sox7
expression is also observed in the dorsal aorta and the
intersomitic vessels but its expression becomes strongly reduced
in the vein at that stage (Fig. 2E). In addition, two discrete stripes
are detected in the hindbrain with the Sox7 probe. As, in
zebrafish, the posterior lateral plate mesoderm contributes
notably to the formation of the vascular and the blood lineages,
we next wanted to define more precisely in which compartment
Sox7 and Sox18 are expressed. We then performed double
fluorescent in situ hybridizations with Flk1 and Scl riboprobes,
that respectively mark endothelial cells and hemangioblasts, on
wild-type embryos at 18 somite stage, at a time point where
populations of cells expressing markers for different lineages
have already spatially migrated and are clearly distinguishable
(Brown et al., 2000; Gering et al., 1998). Transverse sections
from double-stained embryos showed that Sox7 perfectly
colocalizes with Flk1+ cells in two subpopulations of cells.
Fig. 1. Alignment of vertebrate Sox7 and Sox18 peptidic sequences and phylogenetic tree. (A) Residues identical in all proteins are shaded in yellow and those
conserved in just some of them are shaded in blue. Similar aa are shaded in green. The HMG box is indicated by a line. The accession numbers for the sequences are as
follow Dr-Sox7 (AY423014) Hs-Sox7 (NP_113627), Mm-Sox7 (NP_035576), Xl-Sox7 (D83649), Dr-Sox18 (XP_694383 with one modification at position 193
where D is replaced by A), Gg-Sox18 (NP_989640), Hs-Sox18 (NP_060889), Mm-Sox18 (AAB18615) Rn-Sox18 (NP_001019952). Dr: Danio Rerio, Hs: Homo
sapiens. Mm: Mus Musculus, Xl: Xenopus laevis, Rn: Rattus Norvegicus, Gg: Gallus gallus. (B) Phylogenetic tree of the vertebrate Sox7 and Sox18 proteins. The
accession numbers for the sequences are as follow: Dr-Sox17 (AF168614), Dm-SoxF (AJ250955), Dm-SoxE (AJ251580). Dm: Drosophila melanogaster.
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Fig. 2. Spatio-temporal distribution of the zebrafish Sox7 and Sox18 transcripts from bud stage to 28 hpf. (A,F) Posterior views of bud stage embryos indicating that
Sox7 and Sox18 are expressed in stripes corresponding to the LPM. (B,G) Expression of Sox7 and Sox18 in the LPM persists throughout somitogenesis. Staining
occurs at the anterior and the posterior parts of 5 somite embryos. (C,H) At 18 somite stage, a signal corresponding to Sox7 and Sox18 is seen in the presumptive axial
vessels. (D) At 24 hpf, Sox7 is mostly expressed in the DA, the head vessels, the ICM and in two stripes located in the hindbrain. Preferential expression of Sox7 in the
dorsal aorta is confirmed in the close-up view of the midtrunk vasculature shown in panel E. (I) Sox18 transcripts can be detected in the head vasculature, the ICM, the
dorsal aorta and the axial vein. (J) Close-up view of the trunk showing Sox18 expression in both axial vessels at 24 hpf. Lateral (C–E,H–J) or dorsal views (B,G).
Embryos are shown with anterior to the left. The developmental stage is indicated in each panel. DA: dorsal aorta; AV: axial vein; NC: notochord; LPM: lateral plate
mesoderm; ICM: intermediate cell mass. (K–M) Double fluorescent in situ for the vascular marker Flk1 and Sox7 on wild-type embryos at 18 somite stage. Confocal
views of transverse vibratome sections show that Sox7+ positive cells totally overlap with Flk1+ cells. (N–P) Double staining of Scl and Sox7 show a population of
Scl+–Sox7− cells located in the presumptive ICM (arrow in panel P). Panels M and P are merged views counterstained with Topro3 (blue).
408 H. Pendeville et al. / Developmental Biology 317 (2008) 405–416One domain of Flk+/Sox7+ expressing cells is located in the
presumptive dorsal aorta (1 in Figs. 2K–P). These cells no
longer express Scl (compare sections in L and O) and are totally
committed to an endothelial fate. The other domain consists in
two bilateral patches (2 in Fig. 2K–P) that still express Scl and
that are located above the endoderm. These patches of cells most
likely correspond to precursors of endothelial cells that will later
contribute to the formation of the axial vein. Below the dorsal
aorta, in a region corresponding to the ICM (arrows in O,P) there
is a population of Scl-expressing cells that do not express Sox7.
These cells will be committed to the blood lineage. Doublestaining with a Sox18 specific riboprobe showed similar results
(data not shown). From these experiments, we can therefore
conclude that, at 18 S stage, Sox7 and Sox18, like Flk1, become
restricted to the endothelial lineage.
Inhibition of Sox7 and Sox18 leads to a lack of circulation in
the trunk and tail
Because Sox7 and Sox18 are expressed in the lateral plate
mesoderm and then in the axial vessels, we wondered whether
they might have a role in vasculogenesis or angiogenesis. We
409H. Pendeville et al. / Developmental Biology 317 (2008) 405–416therefore used a morpholino antisense knockdown approach to
uncover possible defects in the vasculature caused by Sox 7 and
Sox 18 interference. We used morpholinos designed to target
Sox7 or Sox18 ATG and inhibit translation (MO1Sox7,
MO1Sox18). These were injected either alone or in combination
in fertilized eggs and the phenotype analyzed at 28 hpf, after the
onset of circulation (Fig. 3). No morphological nor circulation
defects were observed in embryos injected with either Sox7 orFig. 3. Knockdown of Sox7 together with Sox18 leads to a loss of circulation in
morpholinos (4 ng of each) prevents trunk circulation in morphants. Sox7 or Sox18 k
assess the functional integrity of the vasculature of 48 hpf control and Sox7/Sox18mo
of MO1 Sox18 and 4 ng of MO1 Sox7, show no uptake of the fluorescent dye where
Sox7/Sox18 knockdown embryos reveals no vascular apparent defect in the posterior
to the left, of embryos at 28 hpf. As evidenced by whole mount in situ with specific r
Tie2 is observed between control embryos and Sox7/Sox18 double morphants. There i
points (data not shown).Sox18 morpholino, despite the fact that these two morpholinos
are very effective in blocking translation (see Supplementary
Fig. 1A). In contrast, combined doses of MO1Sox7 and MO1-
Sox18 resulted in a consistent phenotype, in which the embryos
morphology looked overtly normal but in which circulation in
the trunk and tail was never established. Circulation within the
head vessels was not affected and the heart appeared to beat
normally. The circulation defect eventually resulted inthe trunk and tail. (A) Targeting both Sox7 and Sox18 using different sets of
nockdown alone shows no effect. (B) Left panel: Microangiography analyses to
rphants. The main axial vessels of double morphants embryos, injected with 4 ng
as circulation in the head is not affected. Right panel: Normal Fli1 expression in
vasculature at 28 hpf. (C) Lateral views of the trunk and tail, shown with anterior
iboprobes, no significant difference in the vasculogenic expression of Fli1, Tie1,
s a mild decrease in Flk1 expression at that particular stage but not at earlier time
410 H. Pendeville et al. / Developmental Biology 317 (2008) 405–416pericardial oedema at 3–4 dpf and these embryos died shortly
thereafter. The phenotype is very penetrant as approximately
95% of the double morphants suffer from a lack of circulation
(Fig. 3A). Control embryos, injected with 5-base mismatchFig. 4. Sox7/Sox18morphants display abnormal arterial–venous specification and arte
regular doses of control or Sox7/Sox18morpholinos (4 ng of each) and are fixed at 28
the venous-specific marker Flt4 shows an ectopic expression in the dorsal aorta while
is reduced. Panels C,D,G,H are confocal images of transverse sections of fluorescent e
doses of Sox7/Sox18morpholinos (6 ng of each). As revealed by Flt4 expression, the
markers Notch3, hRT and Dll4 is not affected in double morphants. (L) There is an ab
expression in the brain was not affected. (M) White arrows mark the proximal aorta at
28 hpf Tg(fli1:EGFP)Y1 control fishes show well differentiated proximal aorta wh
Hematoxylin–eosin stained sections reveal arteriovenous shunts in the trunk regionSox7 and Sox18 morpholinos had normal blood cell circulation
within the axial vessels, intersomitic vessels and the dorsal
anastamosing longitudinal vessels. The lack of circulation in the
trunk and tail of Sox7/Sox18 knockdown embryos was clearlyriovenous shunts. Except in panels I,J, all embryos shown resulted of injection of
hpf. Pictures and sections are made at the trunk level. (A–D) In situ staining with
the domain corresponding to the artery-specific marker EphrinB2a (panels E–H)
mbryos labeled by in situ. (I,J) Transverse sections of embryos injected with high
vein is widely expanded, at the expense of the artery. (K) Expression of the artery
olition of Gridlock expression in the double morphants within the aorta while its
the level where the paired lateral dorsal aortae normally fused into a single tube.
ereas morphants display strong dysmorphogenesis of the proximal aorta. (N)
in Sox7/Sox18 morphants. NC=notochord; DA=dorsal aorta; AV=axial vein.
411H. Pendeville et al. / Developmental Biology 317 (2008) 405–416demonstrated by performing a microangiography analysis in
which we injected a fluorescent dye into the sinus venosus of
Sox7/Sox18 morphants and, as control, of Sox7mut/Sox18mut
morphants at 48 hpf (Fig. 3B, left panels).
The specificity of the phenotype was further confirmed by
the injection of another set of morpholinos: one that targets the
second exon–intron junction of Sox7 (MOe2i2 Sox7) and one
second translational Sox18 morpholino (MO2Sox18) whose
effectiveness was confirmed (see Supplementary Fig. 1B).
When both were simultaneously injected, they produced a
similar absence of blood circulation phenotype (Fig. 3A).
Inhibition of Sox7 and Sox18 affects arterial–venous identity
As a first step toward understanding the phenotype observed
following inhibition of Sox7 and Sox18, we performed
microinjections into the Tg(fli1:EGFP)Y1 transgenic line that
drives eGFP expression into endothelial cells and their
angioblasts precursors (Lawson and Weinstein, 2002). Carrying
out knockdown experiments in the Tg(fli1:EGFP)Y1 line shows
that the de novo formation of the main head and axial vessels,
and of the segmental arteries was largely unaffected in the
double morphants in comparison with that in control embryos at
28 hpf (Fig. 3B, right panels). In order to elucidate the cellular
basis of the vascular defect, we next analyzed the expression of
several known markers of endothelial differentiation by whole
mount in situ on 28 hpf control and double Sox7/Sox18
morphants (Fig. 3C). These included the general markers of
endothelial cells Fli1, Flk1 and some endothelium-specific
receptor tyrosine kinases markers such as Tie1 and Tie2 (Brown
et al., 2000; Lyons et al., 1998). The in situ experiments revealed
a slight diminution of Flk1 expression at 28 hpf in the double
morphants while expression of the other genes was not affected.
These data suggest that initial migration of angioblasts
precursors correctly occurred and that the trunk vessels
assemble normally. To test whether the phenotypic effect
could reflect a lack of proper specification of arterial or venous
endothelial cell identity, Sox7/Sox18 morphants were analyzed
for the expression of the arterial marker EphrinB2a and the
venous marker Flt4 (Lawson et al., 2001). These experiments
showed a clear ectopic expression of Flt4 in the dorsal aorta, in
addition to its normal restricted expression in the axial vein at
that stage (Fig. 4, panels A–D). Furthermore, a slight, but
reproducible, reduction of EphrinB2a signal was also observed
in the dorsal aorta of morphants (Fig. 4, panels E–H). We next
tested the expression of other artery markers such as Notch3,
Dll4, hRT and Gridlock (Mailhos et al., 2001; Szeto et al., 2002;
Zhong et al., 2001). Signals corresponding to Notch3, Dll4 and
hRT appeared normal in Sox7/Sox18 morphants, suggesting that
some arterial differentiation has occurred (Fig. 4K). In contrast,
Gridlock expression within the aorta was totally abolished in the
double morphants at 28 hpf while its expression in the brain was
not affected (Fig. 4L). Taken together, these data indicate that
Sox7 and Sox18 act upstream of Gridlock and specify arterial–
venous identity. We could besides emphasize the transfating
phenotype by injecting higher doses of Sox7 and Sox18
morpholinos (6 ng of each). Figs. 4I, J shows that, using higherdoses, the vein is drastically expanded at the expense of the
artery.
In an attempt to explain why the blood does not circulate
into the caudal part of the embryos, we then carefully checked
vessels formation of Sox7/Sox18 morphants into a Tg(fli1:
EGFP) background. Closer inspection of 28 hpf Sox7/Sox18-
injected embryos revealed strong dysmorphogenesis of the
proximal aorta, at the level where the two paired lateral dorsal
aortae fuse into a single tube (Fig. 4M) (Isogai et al., 2001).
Furthermore, histological sections performed through the trunk
of Sox7/Sox18 morphants at 48 hpf also revealed some
abnormalities in the morphology of the main axial vessels
(Fig. 4N). In the control sections, the dorsal aorta and the axial
vein are always clearly distinguishable. In contrast, in
morphants, demarcations between the artery and the vein are
poorly defined, resulting, at some levels of the trunk axis, in
arteriovenous shunts. These morphogenetic defects are
probably the cause of the lack of circulation in the trunk
and tail. Taken together, these data indicate that Sox7 and
Sox18 are required for proper arterial–venous identity and are
necessary to allow primary vessels to display clear arteriove-
nous demarcations.
Hematopoeitic precursors are not affected in Sox7/Sox18
morphants
Since Sox7 and Sox18 are expressed in the lateral plate
mesoderm at early somitogenesis stages, in the region where
vessels, primitive hematopoietic stem cells, and pronephric
development occurs, we next verified whether the other
lineages were disturbed in double morphants. To test whether
the blood lineage was affected, we examined the expression of
two blood markers: Scl/Tal1, a marker of hemangioblast and
Gata1, which is a typical marker for erythroid differentiation,
at 9 and 18 somite stage (Detrich et al., 1995; Gering et al.,
1998) (Fig. 5). At 9 somite stage, we found that the pattern of
Scl expression in the anterior and posterior lateral plate
mesoderm was normal in morphants. Similarly, hybridization
to probes for Scl and Gata1 at 18 somite stage indicated that
abolition of Sox7/Sox18 has no effect on the expression of Scl
and Gata1, which extends along the entire axis in the posterior
region. These data suggested that formation of the hemato-
poietic precursors is unaffected. Finally, in situ hybridization
results with the pronephric duct marker Pax2.1 (Majumdar et
al., 2000) showed no abnormal change in Sox7/Sox18-28 hpf
injected embryos (data not shown).
Sonic Hedgehog and VEGF signaling are required for Sox7
expression
Previous studies have shown that arterial endothelial
differentiation is dependent on a regulatory cascade involving
three signaling pathways, Sonic Hedgehog (Shh), VEGF and
Notch signaling (Gering and Patient, 2005; Lawson et al.,
2002). Shh signaling is first required for the migration of the
dorsal aorta progenitors from the lateral plate to the midline.
Afterwards, Sonic Hedgehog induces the expression of VEGF
Fig. 6. Influence of Shh, VEGF and Notch signaling on Sox7 and Sox18 expression. All embryos are shown at 24 hpf, and pictures were taken from lateral views at the
trunk level. (A) Sox7 expression is lost in Smu mutant embryos and in embryos chemically impaired with cyclopamine whereas Sox18 expression is maintained. (B)
Embryos treated with a VEGF receptor tyrosine kinase inhibitor show no expression of Sox7. Sox18 still appears expressed in these embryos. (C) Sox7 and Sox18
expression are maintained in Mindbomb mutants that are impaired in the Notch signalling.
Fig. 5. Sox7 and Sox18 are not involved in molecular pathways leading to the commitment of mesoderm to a blood fate. At early stages, formation of hematopoietic
precursors appeared unaffected, as evident from normal Scl expression in the posterior LPM at 9 somite stage and from normal Gata1 and Scl expression at 18 somite
stage in Sox7/Sox18 morphants.
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upregulate Notch3 expression. This leads to the activation of
EphrinB2a and to the downregulation of Flt4 expression in
the dorsal aorta at 24 hpf.
To determine where Sox7/Sox18 are placed in this
regulatory cascade, we tested their expression in embryos
defective in these pathways (Fig. 6). We first analyzed the
expression pattern of Sox7 and Sox18 in the Smu mutant
embryos, in which the Shh co-receptor Smoothened is mutated.
In Smu embryos, the angioblasts fail to migrate towards the
midline to form the dorsal aorta under the notochord/
hypochord and do not display any sign of arterial differentia-
tion. Expression of Sox7 was not detected in the trunk of Smu
embryos (Fig. 6A) while its expression was not disturbed in the
head vessels as well as in the two stripes of the hindbrain (data
not shown). On the other hand, Sox18 remains expressed in the
angioblasts. Secondly, we tested Sox7 and Sox18 expression in
embryos treated with cyclopamine, a drug known to block all
Shh signaling. That treatment does not interfere with angioblast
migration but disturbs arterial differentiation as seen by the loss
of the arterial markers Gridlock, Notch3, hrT and ephrinB2a
(Gering and Patient, 2005). Duplicate experiments showed that
treatment of embryos from 90% epiboly with 50 μM
cyclopamine led to a loss of Sox7 expression in the trunk at
24 hpf. Here again, Sox18 expression was retained in drug-
treated embryos (Fig. 6A).
Thirdly, to examine the requirement of VEGF signaling for
Sox7 and Sox18 induction, we treated 90% epiboly embryos
with a VEGF receptor tyrosine kinase inhibitor (Hennequin et
al., 1999). Embryos incubated with 5 μM of drug failed to show
arterial expression of Sox7 at 24 hpf, whereas Sox18 remained
expressed (Fig. 6B). As control to these experiments and, as
previously published, we found no arterial expression of
ephrinB2a in embryos that had undergone exposure to
cyclopamine or the VEGF receptor tyrosine kinase inhibitor.
Finally, we tested whether Sox7 and Sox18 lie downstream
of the Notch pathway by analyzing their expression in the
zebrafish Mindbomb mutants (Mib), that lack an E3 ubiquitin
ligase crucial for Notch signal activation (Jiang et al., 1996).
These mutant embryos show a loss of some arterial markers
such as EphrinB2a and Notch3 while others are retained, like
Gridlock and hrT. In situ experiments showed that wild-type
siblings and embryos homozygous for mibta52b both exhibited
similar expression of Sox7 and Sox18, whereas EphrinB2a
expression was, as reported, abolished in the mibta52b mutants
(Lawson et al., 2001). Taken together, these data indicate that
Sox7 expression in the artery is dependent of Shh and VEGF
but not of Notch signaling, while Sox18 does not seem
dependent of any of these pathways.
Discussion
To gain insights into the function of Sox7 and Sox18 in
blood vessel development, we have examined the expression
and the function of Sox7 and Sox18 in zebrafish embryogenesis.
We show that the two genes are expressed very early during
angioblast cell differentiation and that they act redundantly tocontrol arterial–venous identity, by at least in part, activating
Gridlock in the arterial vessels.
Functional redundancy between F-subgroup Sox factors has
been previously suggested by the contrasting phenotypes of the
Sox18 null mice compared to the ragged mutant mice that
carry mutations in the transactivation domain of Sox18. Indeed,
mice null for Sox18 have only a mild coat defect but no
developmental vascular-associated phenotype (Pennisi et al.,
2000a) while ragged mice display defective cardiovascular and
hair follicle formation. This suggested that the ragged
mutations lead to the synthesis of a modified Sox18 protein
acting in a dominant-negative manner. The mild phenotype of
Sox18 null mice could be explained by functional redundancy
amongst some Sox proteins from the same subgroup such as
Sox7 and Sox17 (Pennisi et al., 2000b). Redundancy between
Sox17 and Sox18 has been recently demonstrated in mice as
Sox17+/−Sox18−/− mutant mice display reduced postnatal neo-
vascularization and early cardiovascular defects (Matsui et al.,
2006; Sakamoto et al., 2007). In developing mouse embryos,
Sox17 is indeed transiently expressed in some endothelial cells
in addition to its well-known expression in endodermal cells. In
zebrafish, it seems unlikely that such redundancy occurs as Sox17
expression is clearly restricted to the endodermal cells and has not
been detected in the vasculature (Alexander and Stainier, 1999).
Sox7, on the other hand, presents an overlapping expression
pattern with Sox18 in the zebrafish vasculature and acts
redundantly with it. As Sox7 is also expressed in the vasculature
in mice it would be interesting to test similar functional
redundancy of Sox7 and Sox18 in that animal model (Sakamoto
et al., 2007).
Combined knockdown of Sox7 and Sox18 in zebrafish
embryos led to a lack of circulation specifically in the trunk and
the tail while circulation in the head was not affected. Cardiac
contractility and size appeared to be normal and no difference in
the signal of a heart-specific Cmcl2 riboprobe could be detected
on 28 hpf double morphant embryos (data not shown)
indicating that the lack of circulation cannot be linked to a
heart defect. The trunk circulation arrest is rather due to strong
dysmorphogenesis of the proximal aorta and to multiple
arteriovenous shunts along the axial vessels. A similar lack of
circulation phenotype is found in many other mutant or
morphant embryos described so far, many of which have
impaired Shh, VEGF or Notch signaling (Brown et al., 2000;
Lawson et al., 2002). For example, mutants of the VEGF
pathway itself often display lack of circulation, poorly formed
dorsal aorta, reduced EphrinB2a expression and A–V shunts
(Covassin et al., 2006; Lawson et al., 2002; Nasevicius et al.,
2000; Ober et al., 2004). In zebrafish, the first markers of
angioblast differentiation appear right after gastrulation in the
lateral plate mesoderm (Fouquet et al., 1997; Liang et al., 2001;
Thisse and Zon, 2002). It is noteworthy that Sox7 and Sox18 are
both detected during that early specification stage, suggesting
that they play a key role in vasculogenesis. The angioblasts
migrate toward the midline in two waves (Jin et al., 2005). The
arterial endothelial precursors migrate first and form a separate
chord of angioblasts under the notochord/hypochord. Then, a
second migration wave occurs, that generates the venous
414 H. Pendeville et al. / Developmental Biology 317 (2008) 405–416vessels located between the aorta and the endoderm. Based on
their different migration waves and on their final location,
arterial and venous endothelial cells receive different signals
from the neighbouring tissues. Arterial identity is controlled by
a signaling cascade where Sonic hedgehog secreted by the
notochord/hypochord induces VEGF expression in the adjacent
somites, which in turns induce Notch signaling in the dorsal
aorta (Lawson et al., 2002). From the 18 somite stage, the
arterial and venous angioblasts start to coalesce at the midline
and undergo subsequent remodelling and differentiation to form
distinct tubes at 26 somite stage. Shortly thereafter (around
∼24 hpf), mature vascular tubes lumenize allowing the
establishment of the circulation. Intersomitic vessels will
eventually develop by angiogenic sprouting from the main
axial vessels. Whole mount in situ experiments performed with
general endothelial markers on 28 hpf Sox7/Sox18 double
morphant embryos have indicated that the dorsal aorta, axial
vein and intersomitic vessel development is correctly initiated.
Primary vascular tubes are present at their proper location, and
express several markers known to denote blood vessels
morphogenesis, such as Flk1, Fli1, Tie1 and Tie2. This implies
that there is no significant defect in angioblasts differentiation,
proliferation and migration, nor in the coalescence of these cells
at the midline. Instead, the main axial vessels remain non-
functional as a consequence of a lack of proper arterial–venous
identity. They fail to fully express EphrinB2a but still exhibit
normal expression of other arterial markers such as hRT,
Notch3 and Dll4, indicating that some arterial differentiation
can still occur in the double morphants. Importantly, they totally
lack Gridlock expression in the artery. Gridlock has been
reported to be an important determinant of the arterial–venous
fate through repression of venous differentiation (Zhong et al.,
2001). In Sox7/Sox18 morphants, two indications allow us to
believe that both genes also act primarily to repress the venous
fate. Firstly, we observe an ectopic expression of the venous
marker Flt4 in the dorsal aorta of morphants at 24 hpf, at a time
where its expression should normally be downregulated to
allow the artery to fully acquire arterial characteristics.
Secondly, Sox7 and Sox18 morpholinos led to an increase of
the vein at the expense of the artery and that transfating
phenotype was clearly emphasized when higher doses of Sox7
and Sox18 morpholinos were injected (Figs. 4I, J). Consistent
with the fact that Gridlock expression is lost in the Sox7/Sox18
morphants, there are strong similarities between the Sox7/Sox18
morphants and the mutant Gridlock, in which trunk but not
head circulation is affected (Zhong et al., 2000), suggesting that
the phenotype of the Sox7/18 morphant is mainly due to the
inhibition of Gridlock expression. Gridlock has been shown to
be dependent of Shh and VEGF signaling but whether Gridlock
expression is downstream or independent of Notch signaling is
still under debate in the literature. Indeed, on one hand, the
expression of Gridlock is increased by activated Notch1 and
blocked by the dominant negative inhibitor of Su(H) (Zhong et
al., 2001) but, on the other hand, Gridlock is still expressed in
the vasculature of mib mutants (Lawson et al., 2001). Similarly
to Gridlock, Sox7 is also dependent of Shh and VEGF signaling
and is still expressed in the vasculature of mib mutants,underscoring their action in the same pathway (Lamont and
Childs, 2006). In contrast, Sox18 remained expressed in
embryos defective for these three signaling pathways. This
correlates with its expression in the venous as well as in the
arterial compartment. It could be surprising, at first glance, that
Sox18 could play a role in the specification of arterial identity
while being expressed in both vessels. This could be explained
by the hypothesis that Sox18 (and Sox7) act in synergy with
another factor present (or active) specifically in the dorsal aorta.
A similar observation was made with the synectin gene,
involved in selective regulation of arterial, but not venous,
growth and branching morphogenesis while this factor is
present in both venous and arterial compartments (Chittenden et
al., 2006). One possibility is that the factor synergizing with
Sox18 and Sox7 is a component of the Notch signaling
pathway. Further studies will be necessary to verify that
hypothesis and to identify such factor.Materials and methods
Zebrafish maintenance
Embryos were collected, raised at 28 °C under standard laboratory
conditions, and staged as described (Kimmel et al., 1995).
Cloning of Sox7 and Sox18 orthologues from zebrafish
Sox7 and Sox18 partial cDNAs were cloned by two rounds of PCR
performed on a pool of cDNAs ranging from 2 hpf to 31 hpf. The primers used
for Sox18 amplification are BP448 and BP449 for the first PCR followed by a
nested PCR with BP479 and BP480, giving rise to a fragment of 502 pb in the
coding region. The primers used for Sox7 amplification are BP458 and BP459
for the first PCR followed by a nested PCR with BP481 and BP482, giving rise
to a fragment of 805 pb in the coding part of the gene. These two fragments were
cloned into a pGEMT-easy vector (Invitrogen) and used as template for
preparing labelled antisense RNA probes. Sequences of the primers used in this
study are the following:
BP448: ATGAATATATCTGAGTCTAGTTGC
BP449: TTATCCTGTAATGCAGGCGCTGTA
BP479: CAGTTCTCAGCCCAGCCAGGTTGC
BP480: CCGGCTCCACTCGCTTCATCTTCT
BP458: CATGGCGGCTCTGATAAGTGCG
BP459: TGGCGTTTATGAAATGCTGTAGTTG
BP481: GTGGAGGAAGCCGAGCGTCTGC
BP482: AAGCCGGCGTTACCTGGATGTGTC
O65: CCCGGATCCAAGTAGCATACAGACGTCCTGG
O66: CCCGAATTCCTGGCCTCTTGACAGCAACTAG
O76: TCGGCTTCCTCCACATATGG
O132: GGGCCATGGACGAATACGCACTTATCAGAG
O133: CCCGGATCCACTGAGCTCTTCAACCACCAGC
Sox7 and Sox18 5′UTR fusion construct and mRNA synthesis
Polymerase chain reaction (PCR) using the primers O65 and O66 was
performed to amplify 79 bp of the 5′UTR and the first 38 nucleotides of the
coding sequence of Sox18. Similarly, the primers O132 and O133 were used
to amplify 161 bp of the 5′UTR of Sox7 followed by the first 30 nucleotides
of the coding sequence. The resulting BamHI/NcoI digested fragments were
cloned in frame with the GFP coding sequence in the pCS2+ construct. The
Sox7 and Sox18 5′ UTR–GFP fusion constructs were linearized with Not1.
Sp6 RNA polymerase was used for in vitro synthesis of capped mRNA
(Ambion, Austin, TX).
415H. Pendeville et al. / Developmental Biology 317 (2008) 405–416Morpholino sequences and injections
The Sox7 and Sox18 morpholinos were designed by Gene Tools and are
complementary to the 5′ sequence near the translation start or to splice junctions.
Their sequences are as follow:
MO1 Sox7: AATACGCACTTATCAGAGCCGCCAT
Moe2i2 Sox7: CAACGTTAAAATCTTACCAAGCATC
MO1 Sox18: CAGATATATTCATTCCAGCAAGACC
MO2 Sox18: ACACGATTAAAGCAAGCTGTTGTCT
Five-base mismatch MO1mut Sox7 (AATAGGCAGTTATGAGAGGCGC-
GAT), MO1mut Sox18 (CACATATATTGATTGCACCAACACC) or standard
control MO were used as controls.
They were dissolved in 1× Danieau buffer at 2 mM and microinjected at the
1–2 cell stage. Regular analyses were performed on double morphant embryos
injected with 4 ng of each morpholino (MO1 Sox7 and MO1 Sox18), at a dose
where the phenotype was very penetrant. However, in Figs. 4I, J, as stipulated, a
higher dose of 6 ng of each morpholino was used to exacerbate the phenotype of
artery–vein transfating (see text for details).
Injected embryos were then grown in the presence of 0.003% 1-phenyl-2-
thiourea until the desired stage, fixed overnight in 4% PFA and stored in 100%
methanol until use.
Plasmids and probes
Antisense riboprobes were made by transcribing linearized cDNA clones
with SP6, T7, or T3 polymerase using digoxigenin or DNP labeling mix (Roche)
according manufacturer's instructions. They were subsequently purified on
NucAway spin columns (Ambion) and ethanol-precipitated. The Gridlock probe
was made by amplifying a fragment corresponding to the 3′-UTR region of the
cDNAwith the following primers: Grlfor: 5′-gtcttcctctacacttgtgcaca-3′, Grlrev:
5′-gtgaaggctagtggaaggatgg-3′. The PCR fragment was cloned in pCRII-Topo
(Invitrogen, CA) and sequenced before transcription.
Microangiography analysis
For microangiography analysis, isolectinB4 (Molecular Probes) was
dissolved at 5 μg/μl in 0.3× Danieau and microinjected into the sinus venosus
as previously described (Isogai et al., 2001).
Wholemount in situ hybridizations, sectioning and imaging
Single wholemount in situ hybridizations were carried out as described
with minor modifications (Thisse et al., 1993). For fluorescent in situ
hybridization, the different antisense riboprobes were labelled with digox-
ygenin labeling mix (Roche) or DNP-11-UTP ribonucleotides (Roche).
Hybridizations were subsequently performed using the TSAi Plus system kit
from Perkin Elmer. Briefly, after permeabilization, hybridization and washes,
28 hpf embryos were blocked in TNT buffer with 0.5% Blocking Reagent and
then incubated with a peroxidase-conjugated anti-FITC preabsorbed antibody
(1:200) for simple fluorescent in situ. The green color was developed with
tyramide-FITC. For double in situ hybridizations, revelation was sequential:
first, the green color was developed with tyramide-FITC. Then, after
inactivation of the first antibody with H2O2, the embryos were incubated
with peroxidase-conjugated anti-DIG preabsorbed antibody (1:200) and the red
color was developed with tyramide-Cy3. Embryos were then extensively
washed in TNT buffer.
Following fluorescent wholemount in situ hybridization analyses, embryos
were refixed in 1% paraformaldehyde, embedded in low-melting agarose and
cut at 150 μm on a Campden Instruments vibratome. Transverse sections at the
level of the trunk were incubated in TO-PRO-3 iodide solution and pictures were
taken by using a Leica TCS SP2 inverted confocal laser microscope (Leica
Microsystems, Germany). For multicolor imaging, FITC, Cy3, and TO-PRO-3®
iodide were visualized by using an excitation wavelength of 488 nm, 543 nm
and 633 nm respectively. The acquisition was set up to avoid any cross-talk of
the three fluorescence emissions. Captured images were exported as TIFFformat files and further processed using Adobe Photoshop and Illustrator CS2
for figure mounting.
To perform histological sections, morphants were dehydrated, embedded
into JB-4 plastic resin (Polysciences, Inc.), and sectioned at 10 μm on a Leica
microtome. Sections were counterstained with hematoxylin–eosin following
standard procedures.
Drug treatments
Cyclopamine and VEGFR-2 tyrosine kinase inhibitor (number: 676475)
were obtained from Calbiochem and were used at a concentration of 50 μm and
5 μM respectively. Zebrafish embryos were soaked in 24-well plates and were
treated with the drugs from 90% epiboly, until they were processed for in situ
experiments. As control for both experiments, embryos from the same batches
were treated with DMSO or ethanol.
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